Anastasiou D: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
|lastname=Anastasiou | |lastname=Anastasiou | ||
|firstname=Dimitrios | |firstname=Dimitrios | ||
| | |institution=Cancer Metabolism Laboratory | ||
The Francis Crick Institute | |||
|address=The Ridgeway | |||
London | |||
The Ridgeway | |area code=NW7 1AA | ||
|country=United Kingdom | |||
|mailaddress=filip.larsen@ki.se | |||
|mailaddress= | |weblink=http://www.crick.ac.uk/dimitrios-anastasiou | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
Revision as of 16:29, 18 May 2016
| Name | Anastasiou Dimitrios, |
|---|---|
| Institution | Cancer Metabolism Laboratory
The Francis Crick Institute |
| Address | The Ridgeway
London, NW7 1AA |
| City | |
| State/Province | |
| Country | United Kingdom |
| [email protected] | |
| Weblink | http://www.crick.ac.uk/dimitrios-anastasiou |
| O2k-Network Lab | UK London Anastasiou D |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Fets 2022 Commun Biol | 2022 | Fets L, Bevan N, Nunes PM, Campos S, Dos Santos MS, Sherriff E, MacRae JI, House D, Anastasiou D (2022) MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine. https://doi.org/10.1038/s42003-022-03805-y |
| Fets 2018 Nat Chem Biol | 2018 | Fets L, Driscoll PC, Grimm F, Jain A, Nunes PM, Gounis M, Doglioni G, Papageorgiou G, Ragan TJ, Campos S, Silva Dos Santos M, MacRae JI, O'Reilly N, Wright AJ, Benes CH, Courtney KD, House D, Anastasiou D (2018) MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG. Nat Chem Biol 14:1032-42. |
